Sotrovimab (so-TROVEE-mab) is a type of medicine called a monoclonal antibody. It has been developed to treat COVID-19. It works by sticking to the spike ...
10. mar. 2022 ... Australian researchers have uncovered resistance mutations to Sotrovimab - a monoclonal antibody treatment developed to minimise the risk of ...
15. apr. 2022 ...Sotrovimab injection is currently being studied for the treatment of coronavirus disease 2019 (COVID-19) caused by the SARS-CoV-2 virus.
1. mar. 2022 ... Table 1: Information to support treatment decisions on oral antivirals or sotrovimab for people with mild-to-moderate COVID-19 who do not ...
17. mar. 2022 ...sotrovimab for the treatment of COVID-19 in adults. This medication became available in limited supply for use in Australia from August 2021 ...
NOTE: Sotrovimab is not an FDA-approved medication; however, it has been authorized for use under an Emergency Use Authorization (EUA) to treat mild to moderate ...
14. mar. 2022 ... The COVID-19 Monoclonal Antibody Efficacy Trial–Intent to Care Early (COMET-ICE) evaluated the efficacy and tolerability of sotrovimab ...